Sonoma Pharmaceuticals Inc (SNOA) Stock Price, Quote & News

Company Profile

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild t...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 800 759 9305

Website: sonomapharma.com

Address:

5445 Conestoga Court, Suite 150, Boulder, United States

ShangVXO Aug. 19 at 11:39 AM

Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $SNOA & $CLIK on my to buy list

0 · Reply

JimmyOcarri Aug. 17 at 8:42 PM

$ALLR $CODX $CABR $SNOA $HUIZ game

1 · Reply

maixem Aug. 12 at 12:08 AM

$SNOA growing revenue, low market cap but history of dilution. Can 10X with the right management

0 · Reply

Zeb01 Aug. 11 at 7:30 PM

$SNOA it’s time.

0 · Reply

ka1954 Aug. 10 at 3:55 PM

$SNOA this stock is dirt

0 · Reply

PLATINUM_TRADES Aug. 10 at 1:59 PM

$SNOA Adds!! No reason this can't see $1.50 or more into the gap! 🚨🚨🚨🚨

0 · Reply

katorvix Aug. 10 at 5:28 AM

$SNOA - has been raising capital. This is arguably the most interesting fundamental + technical combination, although it doesn’t currently satisfy the volume requirement as cleanly as I’d like. My Trading structure Entry: ~$1.10–$1.18 Breakout trigger: $1.30 Next resistance: ~$1.45–$1.50 Potential continuation: $1.75 → $2.00 → $2.50 Invalidation: <$1.00 Goodluck to all 🤑

0 · Reply

PLATINUM_TRADES Aug. 9 at 7:58 PM

$ZJYL I got u over 100% gains Friday fully guided your hand and guide u.. I got more coming week no losses i in August yet.... Another profitable week coming up... I like $SNOA tiny floater into the gap next imo!!

0 · Reply

Zeb01 Aug. 9 at 6:30 PM

$SNOA get ready for next week, this company will become an example for turnover pharma companies.

0 · Reply

Hailight Aug. 7 at 9:33 AM

$SNOA Our first quarter results demonstrate that Sonoma has reached an important inflection point. These results reflect the strength of our commercial strategy, the growing global adoption of hypochlorous acid products, and the operating leverage built into our business model. With new FDA clearances, expanding distribution partnerships, and a strong pipeline of commercial opportunities, we believe we are well positioned to continue delivering profitable growth.

2 · Reply

Sonoma Pharmaceuticals reports Q1 EPS (9c) vs. (76c) last year

Aug 6, 2026, 9:00 AM EDT - 13 days ago

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

2026-06-30T13:05:15.000Z - 7 weeks ago

Sonoma Pharmaceuticals receives 510(k) clearance for Microdacyn solution

Jun 30, 2026, 9:00 AM EDT - 7 weeks ago

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

Jun 16, 2026, 4:15 PM EDT - 2 months ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

2026-04-24T13:32:34.000Z - 4 months ago

Sonoma Pharmaceuticals prices 2.96M shares at $1.35 in public offering

Apr 24, 2026, 9:21 AM EDT - 4 months ago

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

2026-04-17T21:31:03.000Z - 4 months ago

Sonoma Pharmaceuticals files to sell units, no amount given

2026-03-24T12:45:50.000Z - 5 months ago

Sonoma announces U.S. retail launch of advanced burn relief hydrogel

CVS WMT

Mar 24, 2026, 8:30 AM EDT - 5 months ago

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

2026-03-18T13:00:52.000Z - 5 months ago

Sonoma Pharmaceuticals launches Aquanil AD

Mar 18, 2026, 8:30 AM EDT - 5 months ago

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

Feb 10, 2026, 4:10 PM EST - 6 months ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Jan 28, 2026, 4:15 PM EST - 7 months ago

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

RNA

2025-11-13T13:50:15.000Z - 9 months ago

Sonoma Pharmaceuticals’ Reliefacyn Advanced receives NRS Seal of Acceptance

Nov 13, 2025, 8:30 AM EST - 9 months ago

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Nov 6, 2025, 4:01 PM EST - 10 months ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

2025-11-04T14:00:39.000Z - 10 months ago

Sonoma Pharmaceuticals reports Q2 EPS (32c) vs. (59c) last year

Nov 4, 2025, 8:56 AM EST - 10 months ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

2025-10-14T12:40:28.000Z - 11 months ago

Sonoma Pharmaceuticals, Medline launch HOCI wound cleanser

Oct 14, 2025, 8:30 AM EDT - 11 months ago

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

2025-10-07T13:30:41.000Z - 11 months ago

Sonoma Pharmaceuticals lists facial spray under FDA’s MoCRA

Oct 7, 2025, 8:30 AM EDT - 11 months ago

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

Sep 25, 2025, 4:01 PM EDT - 11 months ago

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Aug 26, 2025, 8:30 AM EDT - 1 year ago

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

2025-08-15T00:51:00.000Z - 1 year ago

Why Is Sonoma Pharmaceuticals Stock (SNOA) Up 105% Today?

AMZN WMT

Aug 13, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Aug 7, 2025, 4:15 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Jun 17, 2025, 4:10 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

2025-04-22T20:15:23.000Z - 1 year ago

Sonoma Pharmaceuticals registers acne products in the United Kingdom

Apr 22, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Mar 10, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Feb 25, 2025, 4:01 PM EST - 1 year ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 5, 2025, 4:05 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

2024-12-05T13:50:39.000Z - 1 year ago

Sonoma transitions first products to new EU MDR requirements

Dec 5, 2024, 8:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

2024-11-21T21:20:46.000Z - 1 year ago

Sonoma Pharmaceuticals announces relaunch of dermatology, eye care lines

Nov 21, 2024, 4:06 PM EST - 1 year ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 11, 2024, 4:20 PM EST - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

2024-11-11T14:55:45.000Z - 1 year ago

FDA grants Sonoma 510(k) approval for Microdacyn Hydrogel

2024-11-07T13:55:41.000Z - 1 year ago

Sonoma Pharmaceuticals reports Q2 (59c) vs ($5.75) last year

Nov 7, 2024, 8:45 AM EST - 1 year ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Oct 31, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

2024-10-22T12:45:45.000Z - 1 year ago

Sonoma Pharmaceuticals expands partnership with healthcare distributor

Oct 22, 2024, 8:35 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 21, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sep 19, 2024, 8:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 17, 2024, 8:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 11, 2024, 8:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Aug 28, 2024, 6:10 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 26, 2024, 8:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 21, 2024, 8:45 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 8, 2024, 4:10 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Jul 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jun 17, 2024, 5:00 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

May 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Mar 28, 2024, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 27, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Feb 8, 2024, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Jan 23, 2024, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

Nov 13, 2023, 4:10 PM EST - 3 years ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 3, 2023, 7:30 AM EDT - 3 years ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Oct 26, 2023, 9:10 AM EDT - 3 years ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Aug 15, 2023, 7:30 AM EDT - 3 years ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

ShangVXO Aug. 19 at 11:39 AM

0 · Reply

JimmyOcarri Aug. 17 at 8:42 PM

$ALLR $CODX $CABR $SNOA $HUIZ game

1 · Reply

maixem Aug. 12 at 12:08 AM

$SNOA growing revenue, low market cap but history of dilution. Can 10X with the right management

0 · Reply

Zeb01 Aug. 11 at 7:30 PM

$SNOA it’s time.

0 · Reply

ka1954 Aug. 10 at 3:55 PM

$SNOA this stock is dirt

0 · Reply

PLATINUM_TRADES Aug. 10 at 1:59 PM

$SNOA Adds!! No reason this can't see $1.50 or more into the gap! 🚨🚨🚨🚨

0 · Reply

katorvix Aug. 10 at 5:28 AM

0 · Reply

PLATINUM_TRADES Aug. 9 at 7:58 PM

0 · Reply

Zeb01 Aug. 9 at 6:30 PM

$SNOA get ready for next week, this company will become an example for turnover pharma companies.

0 · Reply

Hailight Aug. 7 at 9:33 AM

2 · Reply

Hailight Aug. 7 at 7:59 AM

$SNOA https://www.sharedeals.de/sonoma-pharmaceuticals-historischer-wendepunkt-darum-fliegt-die-aktie/

1 · Reply

PennySearch Aug. 6 at 3:33 PM

📈 Top Penny Stock Movers by Relative Volume $PAVS — 12.85x RVOL Move: +34% Volume: 28.4M (2.2M average) Market Cap: $5.6M Day Range: 6.03 – 9.70 52-Week Range: 3.76 – 148800.00 $CELZ — 11.40x RVOL Move: +102% Volume: 169.4M (14.9M average) Market Cap: $3.5M Day Range: 1.01 – 1.63 52-Week Range: 0.62 – 6.25 $SNOA — 8.20x RVOL Move: +10% Volume: 1.1M (132.0K average) Market Cap: $2.1M Day Range: 1.17 – 1.30 52-Week Range: 0.85 – 6.92 Momentum and unusual volume are driving attention. Which one are you watching? 👀 Not financial advice.

0 · Reply

invstdwthaple Aug. 6 at 2:21 PM

$XOS ASPN a good short if it can't hold $8. $SNOA may be a play later. Good earnings- low float. $HYLN will be a creeper all day.

0 · Reply

invstdwthaple Aug. 6 at 2:12 PM

$SNOA Give it another hour. After the chopsticks flame out this one may be found. Good news- low float- possibilities.

0 · Reply

Rybod30 Aug. 6 at 1:09 PM

$SNOA Solid PR, trading charts and volume😬🤷‍♂️….

0 · Reply

STACKD0E Aug. 6 at 1:06 PM

$SNOA $FORR $GOAI $VOYG 👁

0 · Reply

Stock_Catcher Aug. 6 at 1:00 PM

$SNOA Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

0 · Reply

Stock_Catcher Aug. 6 at 12:36 PM

$SNOA Scans

0 · Reply

Benderama8 Jul. 28 at 9:30 PM

$SNOA Amy trombly owns a whopping 8k shared. This dumb beotch deserves to be fired. Yet she gave herself a 100k raise. Her agreement calls for 475k guaranteed plus 195k bonus. And if she is fired or company is wound down she gets an incredible 950k base and another 450k bonus automatically. Holy balls is she a terrible leader and a blood sucking vampire. Stay a million miles away.

0 · Reply

AXLFI_HQ Jul. 2 at 10:30 PM

$SNOA FDA regulatory approvals are expanding for healthcare innovations including novel antibiotics, immunotherapies, and precision diagnostics, creating new market opportunities and growth drivers for medical device and pharmaceutical companies. Learn more: https://axlfi.com/themes/357

0 · Reply

BioTuesdays Jun. 30 at 7:23 PM

$SNOA has received a new 510(k) clearance from the FDA for its Microdacyn Wound Irrigation Solution, including expanded claims, clearance for multiple use, and additional packaging configurations. https://biotuesdays.com/2026/06/30/fda-grants-sonoma-510k-clearance-for-microdacyn-wound-irrigation-solution/

0 · Reply

STACKD0E Jun. 30 at 1:25 PM

$VELO $SNOA $JAGX ✨️

0 · Reply

Market Cap	6.32M
Revenue (ttm)	19.53M
Net Income (ttm)	-3.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-16.28%
Debt to Equity Ratio	0.00

Volume	50,800
Avg Vol	173,462
Day's Range	N/A - N/A
Shares Out	4.79M
Stochastic %K	46%
Beta	1.28
Analysts	Strong Sell
Price Target	$14.80